Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.

Medicare Restrictions On Glucose Monitor Mobile App May Bode Ill For Coverage Of Other Telehealth Services

March 13, 2018
A device maker, clinical endocrinologists and advocates for diabetics are asking CMS to reverse a policy that a consultant says sets a bad precedent for Medicare coverage of remote patient-monitoring technologies such as telehealth. At issue is a Medicare policy that prohibits beneficiaries from using an FDA-approved mobile app to send results from a glucose-monitoring device to their doctors, families and caregivers. CMS covers continuous glucose monitoring devices for patients with intensively managed diabetes. The Dexcom G5 monitoring system is...